The Delhi High Court has asked the Central government to explain its failure to fix the maximum retail price (MRP) of coronary stents despite these devices being included in the national essential list of medicines (NLEM) earlier this year.

Coronary stents are used to treat narrowed or weakened arteries in the heart.

“What do you have to say with regard to fixation of MRP of coronary stents,” asked a bench comprisng Chief Justice G Rohini and Justice Sangita Dhingra Sehgal.

The bench issued a notice to the central government and sought its response by December 22.

In a petition to the high court, it has been alleged that the government and the National Pharmaceutical Pricing Authority (NPPA) were being “insensitive and irresponsible” towards the people by not taking any steps to fix the price of such stents which are allegedly being sold at higher rates in the country.

The petition has sought a direction to the NPPA “to control the rate and decide a particular maximum retail price (MRP) of the coronary stents”.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Health Policy